-succinyl--cyclodextrin [2] (1, 209 mg, 0.144 mol, 4 eq) was coupled using EDC (4 eq, 0.144 mmol), DIEA (4 eq, 0.144 mmol) in pyridine/DMF respectively. The peptide was cleaved from the resin [3] [4] . RP-HPLC with a Shimadzu LC-6 system equipped with a 15-µm, 300-Å Phenomenex guard column and a separation column (250 by 21.20 mm) was used to purify the peptides. Wavelength of analysis at 214 nm. Buffer A: 98% H 2 O, 2% MeCN, 0.1% TFA; Buffer B: 90% MeCN, 10% H 2 O, 0.1% TFA. The peptide fractions (50µL) were analysed with either a Waters Alliance HT 2790 HPLC instrument coupled to a Micromass ZMD 4000 ESI-MS using infusion injection or a Waters Alliance Micromass LR-MS (MALDI-TOF) MS using α-cyanohydroxycinnamic acid as the matrix (2 mg/mL in 1:1 acetonitrile:methanol). Collation of the pure fractions and freeze-drying yielded a pure product. The time programme used for purification is given in Table 1 . The product eluted at 42% B as a white fluffy solid (2.0 mg, 2%). Adapted from Liskamp et al [5] . Fmoc-OSu (2.55 g, 7.5 mmol, 1 eq) dissolved in dioxane (5 mL) was added dropwise to a stirred solution of ε-aminocaproic acid (1.00 g, 7.5 mmol, 1 eq) and NaCO 3 (0.804 g, 7.5 mmol, 1 eq) dissolved in water (5 mL). This solution was stirred overnight at rt. The solvent was removed in vacuo and the resiude was then dissolved in EtOAc (40 mL) and acidified with HCl (50 mL, 1 mol/L). The solution was extracted with ether (1 x 50 mL) and the organic layer was washed with water (2x 50 mL) and the organic Peptide synthesis as per 6 was used to synthesise the N-terminal peptide sulfonamide 7 on Rink resin. Briefly, Rink resin was swollen in DMF overnight followed by deprotection using 20% piperidine in DMF solution (2 x 5 minutes). Amino acids (4 eq) were coupled to the resin using TBTU (4 eq), HOBt (4 eq), DIEA (8 eq) in DMF with the coupling time depending upon the amino acid. 4-Carboxybenzenesulfonamide (4 eq) was coupled to the resin using TBTU (4 eq), HOBt (4 eq), DIEA (8 eq) in DMF overnight. A Kaiser test 13 was used to determine if each Fmoc-protected amino acid coupling was successful. TFA cleavage and RP-HPLC purification were as per 2 with the pure product eluting at 41% B (12 mg, 4%). Analogue 7 was assembled manually on Rink resin (0.073 mmol, 100 mg, 1 eq). The resin was swollen overnight in DMF (100%). 20% Piperidine in DMF (2 x 10 minutes) was used
LR-MS (MALDI)
for Fmoc deprotection of all the amino acids. Fmoc-L-amino acids (2.00 mmol, 4 eq) were coupled overnight (followed by a second recoupling) using TBTU (2.00 mmol, 4 eq) and DIEA (4.00 mmol, 8 eq) in excess as activating agents. The Kaiser test was used to determine whether the amino acids had coupled successfully. The incorporation of a C-terminal sulfonamide onto the peptides was achieved using Fmoc-aminobenzenesulfonylchloride (11, 4 eq) coupling directly onto deprotected Rink resin with a 1:1 pyridine in DCM slurry overnight followed by a Kaiser test Peptide synthesis as per 6 was employed to synthesise the N-and C-terminal peptide sulfonamide ix on Rink resin. Briefly, Rink resin was swollen in DMF overnight followed by deprotection using a 20% piperidine in DMF solution (2 x 5 minutes). Amino acids (4 eq) were coupled to the resin using TBTU (4 eq), HOBt (4 eq), DIEA (8 eq) in DMF with the coupling time depending upon the amino acid. A Kaiser test Adapted from Liskamp et al [5] . 4-aminobenzenesulfonic acid (1.0 g, 2.5 mmol, 1 eq), dry toluene (50 mL), dry DMF (5 mL), and excess thionyl chloride (2 mL) were allowed to stir at rt overnight followed by quenching with ice-water, neutralisation with NaHCO 3 and extraction of the aqueous phase with EtOAc (2 x 10 mL). The organic phase was then concentrated in vacuo and recrystallised (twice) with a benzene/hexane mixture forming a white solid (11, 620 mg, 60%). To further assess the nature of 11, 50 mg of the sample was dissolved in DMSO. TEA (1.1 eq) and benzylamine (1.1 eq) was added, and the reaction allowed to stir at rt overnight. MS results showed presence of the (M+2H) +2 peak for analogue 12. A loss of the Fmoc group was also observed. It is also noted that the solubility of the chloride species (11, soluble in DMF) was notably different from the 4-aminobenzenesulfonic acid starting material, only sparingly soluble in DMSO).
Stability tests
Before addition to the resin, analogue 11 was tested for its stability under standard Fmoc-SPPS reaction conditions. These conditions and results are given in Table 2 . 
Fmoc-UV coupling tests
Coupling tests were performed on analogue 11 to see if the exchange of the acid group for a sulfonyl chloride group would aid its coupling to Rink resin. For Fmoc coupling test details refer to White and Chan [6] . The conditions tested and results are given in Table 3 . The coupling of 11 to Sieber resin using the same method was also tested. Experimental details and results are given in Table 3 with the highlighted results used in the rest of this study. 
